scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
2.480
0.00 (0.00%)
May 12, 2025, 4:00 PM - Market open
scPharmaceuticals Employees
As of December 31, 2024, scPharmaceuticals had 164 total employees, including 162 full-time and 2 part-time employees. The number of employees increased by 28 or 20.59% compared to the previous year.
Employees
164
Change (1Y)
28
Growth (1Y)
20.59%
Revenue / Employee
$221,537
Profits / Employee
-$519,195
Market Cap
124.70M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SCPH News
- 5 days ago - scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025 - GlobeNewsWire
- 11 days ago - scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025 - GlobeNewsWire
- 2 months ago - scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease - GlobeNewsWire
- 2 months ago - scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire